CORMEDIX INC. ANNOUNCES RESUBMISSION of NEW DRUG APPLICATION FOR DEFENCATH

Written by Sam Nelson on February 28, 2022

Berkeley Heights, NJ – February 28, 2022 – CorMedix Inc. (Nasdaq:…